Caplacizumab recommended to treat acute acquired thrombotic thrombocytopenic purpura

Adding caplacizumab is likely to reduce the long-term complications of acquired TTP and risk of death, according to NICE final draft guidance.

Please sign in or register for FREE

No comments yet.